Mitotane-13C6 is used for the study of adrenocortical carcinoma; it exhibits adrenolytic activity partially through inducing lipotoxicity via intracellular free cholesterol accumulation; it exerts direct pituitary effects on corticotroph cells; and it induces CYP3A4 gene expression via steroid and xenobiotic receptor (SXR) activation.